PROTEIN KINASE A INHIBITOR FRAGMENT 14-22, MYRISTOYLATED TRIFLUOROACETATE SALT
PROTEIN KINASE A INHIBITOR FRAGMENT 14-22, MYRISTOYLATED TRIFLUOROACETATE SALT Basic information
- Product Name:
- PROTEIN KINASE A INHIBITOR FRAGMENT 14-22, MYRISTOYLATED TRIFLUOROACETATE SALT
- Synonyms:
-
- PROTEIN KINASE A INHIBITOR FRAGMENT 14-22, MYRISTOYLATED TRIFLUOROACETATE SALT
- MF:
- C55H101F3N20O14
- MW:
- 1323.51
- Product Categories:
-
- Serine/Threonine Kinase Inhibitors
- Cyclic Nucleotide Metabolism
- Cyclic Nucleotides and AnalogsSerine/Threonine Kinase Biology
- G Proteins and Cyclic Nucleotides
- Protein Kinase A (PKA)
- Mol File:
- Mol File
More
Less
PROTEIN KINASE A INHIBITOR FRAGMENT 14-22, MYRISTOYLATED TRIFLUOROACETATE SALT Chemical Properties
- storage temp.
- -20°C
- form
- lyophilized powder
More
Less
Safety Information
- Safety Statements
- 22-24/25
- WGK Germany
- 3
More
Less
PROTEIN KINASE A INHIBITOR FRAGMENT 14-22, MYRISTOYLATED TRIFLUOROACETATE SALT Usage And Synthesis
Uses
Protein kinase A inhibitor fragment 14-22, myristoylated trifluoroacetate salt has been used in cell culture for pharmaceutical inhibition and activation studies.
General Description
Protein kinase A inhibitor fragment 14-22, myristoylated trifluoroacetate salt inhibits the protein kinase cAMP-activated catalytic subunit-α (PRKACA). The gene encoding it is localized on human chromosome 19p13.1.
Biochem/physiol Actions
Mutations in the gene encoding protein kinase cAMP-activated catalytic subunit-α (PRKACA) have been associated with Cushing′s syndrome.